Qiagen N.V. Common Shares (QGEN)

Cost of Revenue

$801.85M

TTM · Period ending: · USD

QGEN logo

QGEN Cost of Revenue

Latest reported$801.85M
QGEN TTM Cost of Revenue ($2.80M → $801.85M)
High-resolution chart · PNG

QGEN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Qiagen N.V. Common Shares Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
801,846,000
806,446,000
798,504,000
763,265,000
755,503,000
1,017,832,000
1,010,864,000
1,016,014,000
1,000,386,000
721,508,000
731,623,000
719,021,000
719,667,000
721,456,000
756,955,000
785,069,000
804,017,000
817,643,000
800,837,000
790,064,000
755,525,000
705,687,000
637,631,000
573,737,000
538,492,000
525,907,000
521,162,000
525,674,000
519,065,000
506,808,000
500,888,000
498,054,000
500,015,000
501,008,000
494,975,000
497,703,000
492,232,000
491,399,000
493,144,000
480,054,000
472,344,000
467,660,000
454,611,000
474,021,000
477,389,000
473,441,000
479,839,000
460,428,000
458,556,000
489,885,000
486,493,000
475,280,000
469,001,000
426,943,000
430,432,000
449,124,000
445,345,000
434,874,000
419,939,000
384,246,000
376,690,000
372,834,000
371,869,000
375,826,000
368,676,000
359,420,000
342,752,000
321,517,000
312,731,000
301,887,000
293,285,000
284,982,000
267,565,000
239,330,000
212,377,000
178,690,000
154,413,000
146,752,000
141,168,000
132,948,000
126,788,000
125,936,000
123,194,000
124,958,000
125,653,000
125,083,000
127,112,000
131,135,000
131,822,000
129,490,000
122,404,000
111,752,000
106,816,000
101,009,000
96,508,000
93,993,000
87,510,000
83,427,000
79,673,000
70,156,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.